Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Morgan

Showing results (151-160 of 282) with videos related to

Pageof 29
Sort By:
Psychopharmacology|June 24, 2021
Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ<sup>9</sup>-THC)Angela N Henderson-Redmond, Diana E Sepulveda, Erin L Ferguson, et al.
JAMA Pediatrics|February 19, 2019
2018 Update on Pediatric Medical Overuse: A ReviewEric R Coon, Ricardo A Quinonez, Daniel J Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2019
The Effectiveness of Contact Precautions on Methicillin-Resistant Staphylococcus aureus in Long-term Care Across the United StatesDaniel J Morgan, Min Zhan, Michihiko Goto, et al.
Frontiers in Molecular Biosciences|July 12, 2021
Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic PainAngela N Henderson-Redmond, LaTaijah C Crawford, Diana E Sepulveda, et al.
JAMA Internal Medicine|August 23, 2017
Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011Peter Doshi, Peter Hur, Mark Jones, et al.
Infection Control and Hospital Epidemiology|September 15, 2017
Can National Healthcare-Associated Infections (HAIs) Data Differentiate Hospitals in the United States?Max Masnick, Daniel J Morgan, John D Sorkin, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2025
ProSAAS neuropeptides and receptors GPR171 and GPR83: Potential therapeutic applications for pain, anxiety, and body weight regulationLloyd D Fricker, Amanda K Fakira, Erin N Bobeck, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral NeuropathyRobert C Barnes, Henry Blanton, Canice Lei Dancel, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 29, 2023
Erratum: Considerations for de-escalating universal masking in healthcare centers - CORRIGENDUMGabriel Birgand, Caroline Landelle, James R Price, et al.
Infection Control and Hospital Epidemiology|February 25, 2015
Effect of chlorhexidine bathing and other infection control practices on the Benefits of Universal Glove and Gown (BUGG) trial: a subgroup analysisDaniel J Morgan, Lisa Pineles, Michelle Shardell, et al.
Pageof 29

Showing results (151-160 of 282) with videos related to

Sort By:
Pageof 29
Psychopharmacology|June 24, 2021
Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ<sup>9</sup>-THC)Angela N Henderson-Redmond, Diana E Sepulveda, Erin L Ferguson, et al.
JAMA Pediatrics|February 19, 2019
2018 Update on Pediatric Medical Overuse: A ReviewEric R Coon, Ricardo A Quinonez, Daniel J Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2019
The Effectiveness of Contact Precautions on Methicillin-Resistant Staphylococcus aureus in Long-term Care Across the United StatesDaniel J Morgan, Min Zhan, Michihiko Goto, et al.
Frontiers in Molecular Biosciences|July 12, 2021
Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic PainAngela N Henderson-Redmond, LaTaijah C Crawford, Diana E Sepulveda, et al.
JAMA Internal Medicine|August 23, 2017
Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011Peter Doshi, Peter Hur, Mark Jones, et al.
Infection Control and Hospital Epidemiology|September 15, 2017
Can National Healthcare-Associated Infections (HAIs) Data Differentiate Hospitals in the United States?Max Masnick, Daniel J Morgan, John D Sorkin, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2025
ProSAAS neuropeptides and receptors GPR171 and GPR83: Potential therapeutic applications for pain, anxiety, and body weight regulationLloyd D Fricker, Amanda K Fakira, Erin N Bobeck, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 27, 2024
Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral NeuropathyRobert C Barnes, Henry Blanton, Canice Lei Dancel, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 29, 2023
Erratum: Considerations for de-escalating universal masking in healthcare centers - CORRIGENDUMGabriel Birgand, Caroline Landelle, James R Price, et al.
Infection Control and Hospital Epidemiology|February 25, 2015
Effect of chlorhexidine bathing and other infection control practices on the Benefits of Universal Glove and Gown (BUGG) trial: a subgroup analysisDaniel J Morgan, Lisa Pineles, Michelle Shardell, et al.
Pageof 29